Vulvar cancer outcomes endometrial cancer vulvar neoplasms. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy7

Groin Vulva Lymph Nodes Cell Line, Tumor Endometrium Tumor Cells, Cultured Neoplastic Stem Cells

Organisms2

Papillomaviridae Mice, Nude

Diseases64

Vulvar Neoplasms Endometrial Neoplasms Breast Neoplasms Genital Neoplasms, Female Vaginal Neoplasms Neoplasms Carcinoma, Squamous Cell Carcinoma, Endometrioid Prostatic Neoplasms Lichen Sclerosus et Atrophicus Neoplasm Recurrence, Local Carcinoma in Situ Anus Neoplasms Uterine Cervical Neoplasms Ovarian Neoplasms Lung Neoplasms Pancreatic Neoplasms Neoplasm Invasiveness Papillomavirus Infections Adenocarcinoma Colonic Neoplasms Endometrial Hyperplasia Stomach Neoplasms Colorectal Neoplasms Uterine Neoplasms Neoplasm Metastasis Urinary Bladder Neoplasms Disease Progression Lymphatic Metastasis Carcinoma Genetic Predisposition to Disease Cystadenocarcinoma, Serous Neoplasms, Second Primary Neoplasms, Multiple Primary Skin Neoplasms Colorectal Neoplasms, Hereditary Nonpolyposis Adenocarcinoma, Clear Cell Liver Neoplasms Carcinoma, Non-Small-Cell Lung Cell Transformation, Neoplastic Rectal Neoplasms Kidney Neoplasms Cystadenocarcinoma, Papillary Thyroid Neoplasms Neoplasms, Hormone-Dependent Adenocarcinoma, Mucinous Neoplasms, Radiation-Induced Neoplasms, Cystic, Mucinous, and Serous Bone Neoplasms Neoplasms, Glandular and Epithelial Gastrointestinal Neoplasms Precancerous Conditions Esophageal Neoplasms Mouth Neoplasms Adenocarcinoma, Papillary Head and Neck Neoplasms Carcinoma, Papillary Carcinoma, Pancreatic Ductal Neoplasms, Experimental Neovascularization, Pathologic Microsatellite Instability Testicular Neoplasms Adenoma Mixed Tumor, Mullerian

Chemicals and Drugs36

Tumor Markers, Biological Neoplasm Proteins Receptors, Estrogen Prostate-Specific Antigen Tamoxifen DNA, Neoplasm Antineoplastic Agents Estrogens Receptors, Progesterone Cancer Vaccines Antineoplastic Agents, Hormonal RNA, Messenger Antigens, Neoplasm Receptor, erbB-2 Progestins RNA, Small Interfering Tumor Suppressor Protein p53 Estrogen Antagonists PTEN Phosphohydrolase Paclitaxel Tumor Suppressor Proteins Estrogen Receptor alpha Cisplatin Nuclear Proteins Contraceptives, Oral Anticarcinogenic Agents DNA-Binding Proteins RNA, Neoplasm Fluorouracil MicroRNAs Antineoplastic Agents, Phytogenic Antibodies, Monoclonal Estrogen Receptor Modulators Proto-Oncogene Proteins Proto-Oncogene Proteins c-akt Selective Estrogen Receptor Modulators

Analytical, Diagnostic and Therapeutic Techniques and Equipment63

Prognosis Neoplasm Staging Treatment Outcome Early Detection of Cancer Survival Analysis Risk Factors Lymph Node Excision Registries Sentinel Lymph Node Biopsy Retrospective Studies Incidence Follow-Up Studies Survival Rate SEER Program Prospective Studies Cohort Studies Risk Assessment Kaplan-Meier Estimate Disease-Free Survival Gene Expression Profiling Risk Chemotherapy, Adjuvant Prostatectomy Multivariate Analysis Case-Control Studies Hysterectomy Logistic Models Odds Ratio Predictive Value of Tests Oligonucleotide Array Sequence Analysis Mammography Reverse Transcriptase Polymerase Chain Reaction Proportional Hazards Models Immunohistochemistry Clinical Trials as Topic Radiotherapy Antineoplastic Combined Chemotherapy Protocols Mastectomy Reproducibility of Results Questionnaires Sensitivity and Specificity Neoplasm Grading Combined Modality Therapy Xenograft Model Antitumor Assays Blotting, Western Neoplasm Transplantation Pregnancy Outcome Estrogen Replacement Therapy Confidence Intervals Polymerase Chain Reaction Immunoenzyme Techniques Salpingectomy Body Mass Index Transplantation, Heterologous Molecular Targeted Therapy Tissue Array Analysis Drug Screening Assays, Antitumor Tumor Burden Randomized Controlled Trials as Topic Radiotherapy, Adjuvant Biopsy Neoplasms, Experimental Transfection

Psychiatry and Psychology1

Phenomena and Processes38

Gene Expression Regulation, Neoplastic Risk Genetic Predisposition to Disease Odds Ratio Time Factors Postmenopause Mutation Drug Resistance, Neoplasm Genotype DNA Methylation Sensitivity and Specificity Pregnancy Outcome Cell Proliferation Germ-Line Mutation Polymorphism, Genetic Apoptosis Cell Growth Processes Cell Survival Gene Silencing Down-Regulation Body Mass Index Menopause Cell Division Dose-Response Relationship, Drug Cell Cycle Cell Movement Genes, Tumor Suppressor Promoter Regions, Genetic Microsatellite Repeats Premenopause Diet Microsatellite Instability Signal Transduction Parity Genes, Neoplasm Up-Regulation Transfection Genes, BRCA1

Disciplines and Occupations3

Outcome Assessment (Health Care)Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena3

Quality of Life National Cancer Institute (U.S.)Socioeconomic Factors

Humanities1

Quality of Life

Information Science5

Registries Incidence Survival Rate SEER Program Questionnaires

Named Groups4

European Continental Ancestry Group African Americans Survivors Hispanic Americans

Health Care34

Treatment Outcome Survival Analysis Risk Factors Registries Retrospective Studies Incidence Follow-Up Studies Survival Rate SEER Program Prospective Studies Outcome Assessment (Health Care)Cohort Studies Risk Assessment Kaplan-Meier Estimate Disease-Free Survival Risk Multivariate Analysis Case-Control Studies Logistic Models Odds Ratio Predictive Value of Tests Age Factors Proportional Hazards Models Clinical Trials as Topic Reproducibility of Results Questionnaires Sensitivity and Specificity Healthcare Disparities National Cancer Institute (U.S.)Socioeconomic Factors Confidence Intervals Body Mass Index Randomized Controlled Trials as Topic Parity

Geographicals4

United States China Sweden Japan

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Vulvar Neoplasms Endometrial Neoplasms Groin Vulva Breast Neoplasms Genital Neoplasms, Female Vaginal Neoplasms Prognosis Neoplasm Staging Treatment Outcome Neoplasms Carcinoma, Squamous Cell Carcinoma, Endometrioid Prostatic Neoplasms Lichen Sclerosus et Atrophicus Early Detection of Cancer Neoplasm Recurrence, Local Carcinoma in Situ Survival Analysis Risk Factors Lymph Node Excision Registries Anus Neoplasms Uterine Cervical Neoplasms Ovarian Neoplasms Sentinel Lymph Node Biopsy Tumor Markers, Biological Retrospective Studies Lung Neoplasms Incidence Pancreatic Neoplasms Follow-Up Studies Gene Expression Regulation, Neoplastic United States Survival Rate Neoplasm Invasiveness SEER Program Prospective Studies Outcome Assessment (Health Care)Papillomavirus Infections Lymph Nodes Cohort Studies Risk Assessment Adenocarcinoma Kaplan-Meier Estimate Colonic Neoplasms Disease-Free Survival Endometrial Hyperplasia Stomach Neoplasms Colorectal Neoplasms Gene Expression Profiling Uterine Neoplasms Neoplasm Metastasis Urinary Bladder Neoplasms Neoplasm Proteins Disease Progression Risk Receptors, Estrogen Lymphatic Metastasis Chemotherapy, Adjuvant Prostatectomy Carcinoma Cell Line, Tumor Genetic Predisposition to Disease Multivariate Analysis Case-Control Studies Prostate-Specific Antigen Hysterectomy Papillomaviridae Mice, Nude Tamoxifen Logistic Models Odds Ratio European Continental Ancestry Group Endometrium DNA, Neoplasm African Americans Predictive Value of Tests Time Factors Cystadenocarcinoma, Serous Oligonucleotide Array Sequence Analysis Neoplasms, Second Primary Neoplasms, Multiple Primary Mammography Antineoplastic Agents Age Factors Reverse Transcriptase Polymerase Chain Reaction Quality of Life Proportional Hazards Models Immunohistochemistry Postmenopause Clinical Trials as Topic Radiotherapy Estrogens Receptors, Progesterone Mutation Antineoplastic Combined Chemotherapy Protocols Cancer Vaccines Antineoplastic Agents, Hormonal Mastectomy

No FAQ available that match "vulvar cancer outcomes endometrial cancer vulvar neoplasms"